Screener
Corvus Pharmaceuticals CRVS Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Corvus Pharmaceuticals’s reported figures.
The source filing: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-057100
FAQ
- What is Corvus Pharmaceuticals's invested capital?
- Corvus Pharmaceuticals (CRVS) reported invested capital of $201.41M in Q1 2026.
- How has Corvus Pharmaceuticals's invested capital changed year-over-year?
- Corvus Pharmaceuticals's invested capital increased by 342.9% year-over-year, from $45.48M to $201.41M.
- What is the long-term trend for Corvus Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's invested capital has grown at a -0.2% compound annual growth rate (CAGR), from $58M to $57.57M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Corvus Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude